Robin Farmanfarmaian

Professional Speaker & Entrepreneur

📍 Palo Alto, California, United States🔄 Updated September 2026💼 3 investments📅 11 years investing🗓 Last invested Dec 2017𝕏 @upgrade_to_unlock
VC🌍 United States
3
Total investments
1
Early stage
1
Mid stage
1
Late stage
11y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Dec 2017
Aerami Therapeutics is breathing life into the treatment of serious and rare cardiopulmonary conditions with a mission-driven objective: develop products that help patients live longer and help them live better. We do this by combining precision medicines and advanced administration platforms that support ease-of-use and quality-of-life. Our lead program, AER-901 (inhaled imatinib) in pulmonary hypertension, has been intentionally designed to potentially reverse the damage caused by disease progression while overcoming many of the limitations of oral, parenteral, and other inhaled delivery technologies. To learn more, visit: https://aerami.com/ #Aerami #Cardiopulmonary #PulmonaryHypertension #PulmonaryArterialHypertension #PH #PAH #ILD #HeartDisease #LungDisease #InhaledTherapeutics #AER901 #AER601
Angel Investor
Aug 2016
Refection helps you track & analyse everything you need to know about the performance your own apps, competitors, and platforms. Our mission is to make app market insight accessible and easy to understand for everyone in the app industry. http://www.reflection.io
mid stageInternet
Angel Investor & VP, Business Development
Jan 2015
Invicta Medical is a medical technology company that specializes in innovative therapies for sleep apnea.
Experience · 11 entries
All (11)
Investments (3)
Founder (6)
2024
Co-founder and CCO
Aug 2024
i-GENTIC is a vertical-agnostic Agentic AI governance execution platform for regulated enterprises. We help organizations move beyond static policies, manual audits, and after-the-fact compliance by turning regulations, SOPs, and quality requirements into real-time, enforceable governance that runs directly across data, AI, systems, and workflows. Instead of documenting controls and hoping they are followed, i-GENTIC executes them continuously and produces audit-ready evidence by design. What i-GENTIC enables -Real-time governance of data, AI, APIs, and workflows -Continuous enforcement of SOPs and Quality Management Systems (QMS) -Post-market surveillance and real-world evidence governance -Ongoing alignment with evolving regulations including FDA, HIPAA, GDPR, EU MDR, and emerging AI regulations -Multilingual global consistency with a single source of truth -Always-on audit readiness with provable control execution
2020
Co-Founder
Mar 2020
The Apple Watch App to Stop Touching Your Face, and Reduce Your Risk of Catching the Coronavirus We All Touch Our Faces Almost all adults say they don't touch their faces. But observational studies show that we all do it many times each hour. It's unconscious. It Matters With the outbreak of the coronavirus, our society has become more aware of why it matters. And we're all trying to stop doing it. Our Solution Our Silicon Valley team of doctors and entrepreneurs is making a change. We've built an Apple Watch app that beeps and vibrates when you touch your face.
2019
CEO & Co-founder
Jun 2019
ArO’s wireless, dynamic glasses will measure, correct and enhance a user’s vision, while overlaying their environment with interactive information and communication. Traditional corrective or AR lenses are replaced with OLEDs, and by using bluetooth/5G, the heavy computing power is offloaded to a nearby device, resulting in lightweight frames that can be worn all day.
2017
Angel Investor
Dec 2017
Aerami Therapeutics is breathing life into the treatment of serious and rare cardiopulmonary conditions with a mission-driven objective: develop products that help patients live longer and help them live better. We do this by combining precision medicines and advanced administration platforms that support ease-of-use and quality-of-life. Our lead program, AER-901 (inhaled imatinib) in pulmonary hypertension, has been intentionally designed to potentially reverse the damage caused by disease progression while overcoming many of the limitations of oral, parenteral, and other inhaled delivery technologies. To learn more, visit: https://aerami.com/ #Aerami #Cardiopulmonary #PulmonaryHypertension #PulmonaryArterialHypertension #PH #PAH #ILD #HeartDisease #LungDisease #InhaledTherapeutics #AER901 #AER601
2016
Angel Investor
Aug 2016
Refection helps you track & analyse everything you need to know about the performance your own apps, competitors, and platforms. Our mission is to make app market insight accessible and easy to understand for everyone in the app industry. http://www.reflection.io
mid stageInternet
Show all 11 entries ↓
Investment activity
2015–2017 · 3 investments
201512016120171
Recent (last 2 years)Earlier